Skip to main content

Table 5 Summary of EQA control samples processed for IDR method validation

From: Affordable drug resistance genotyping of HIV-1 reverse transcriptase, protease and integrase genes, for resource limited settings

Sample IDs

IDR IDs

Genes compared

HIV-1 subtype

Mutations

11.02A

EQA01

IN

A

IN: None

AA05694017

EQA02

PR and RT

C

PI: L10F,D30N,N88D

NRTI: M41L,E44D,D67N,T69D,M184V,L210W,T215Y

NNRTI: A98G

AA05694021

EQA03

PR and RT

D

PI: None

NRTI: None

NNRTI: None

AA05694023

EQA04

PR and RT

C

PI: M46I,I54V,V82A

NRTI: M184V

NNRTI: None

AA05694704

EQA05

PR, RT and IN

C

PI: None

NRTI: D67N,K70R,M184V,K219Q

NNRTI: None

IN: None

AA05694734

EQA06

PR, RT and IN

D

PI: None

NRTI: None

NNRTI: None

IN: None

AA05694741

EQA07

PR, RT and IN

C

PI: L10F,D30N,N88D

NRTI: M41L,E44D,D67N,T69D,M184V,L210W,T215Y

NNRTI: A98G

IN: None

  1. EQA external quality assessment; IN integrase; NA not applicable; NRTI nucleoside reverse transcriptase inhibitor; NNRTI non-nucleoside reverse transcriptase inhibitor; PI protease inhibitor; PR protease; RT reverse transcriptase